Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship
- PMID: 34050922
- DOI: 10.1111/eci.13622
Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship
Abstract
According to the 'multiple-hit' hypothesis, several factors can act simultaneously in nonalcoholic fatty liver disease (NAFLD) progression. Increased nitro-oxidative (nitroso-oxidative) stress may be considered one of the main contributors involved in the development and risk of NAFLD progression to nonalcoholic steatohepatitis (NASH) characterized by inflammation and fibrosis. Moreover, it has been repeatedly postulated that mitochondrial abnormalities are closely related to the development and progression of liver steatosis and NAFLD pathogenesis. However, it is difficult to determine with certainty whether mitochondrial dysfunction or oxidative stress are primary events or a simple consequence of NAFLD development. On the one hand, increasing lipid accumulation in hepatocytes could cause a wide range of effects from mild to severe mitochondrial damage with a negative impact on cell fate. This can start the cascade of events, including an increase of cellular reactive nitrogen species (RNS) and reactive oxygen species (ROS) production that promotes disease progression from simple steatosis to more severe NAFLD stages. On the other hand, progressing mitochondrial bioenergetic catastrophe and oxidative stress manifestation could be considered accompanying events in the vast spectrum of abnormalities observed during the transition from NAFL to NASH and cirrhosis. This review updates our current understanding of NAFLD pathogenesis and clarifies whether mitochondrial dysfunction and ROS/RNS are culprits or bystanders of NAFLD progression.
Keywords: ROS; mitochondria; mitochondrial dysfunction; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; oxidative stress.
© 2021 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-357.
-
- Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84.
-
- Wong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;148(3):547-555.
-
- Haldar D, Kern B, Hodson J, et al. Outcomes of liver transplantation for non-alcoholic steatohepatitis: a European Liver Transplant Registry study. J Hepatol. 2019;71(2):313-322.
-
- Krawczyk M, Liebe R, Lammert F. Toward genetic prediction of nonalcoholic fatty liver disease trajectories: PNPLA3 and Beyond. Gastroenterology. 2020;158(7):1865-1880.e1.
Publication types
MeSH terms
Grants and funding
- 722619/H2020 Marie Skłodowska-Curie Actions
- 734719/H2020 Marie Skłodowska-Curie Actions
- IP2015 022074/Ministerstwo Nauki i Szkolnictwa Wyższego
- ST 46/Ministerstwo Nauki i Szkolnictwa Wyższego
- POCI-01-0145-FEDER-029152/Foundation for Science and Technology (FCT)
- PTDC/ASP-HOR/29152/2017/Foundation for Science and Technology (FCT)
- UIDB/04539/2020/Foundation for Science and Technology (FCT)
- UMO-2015/17/D/NZ1/00030/Narodowe Centrum Nauki
- UMO-2018/29/B/NZ1/00589/Narodowe Centrum Nauki
- UMO-2020/36/T/NZ1/00004/Narodowe Centrum Nauki
- Operational Program Competitiveness Factors COMPETE
- European Reference Network on Hepatological Diseases (ERN RARE-LIVER).
- European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
